Wells Fargo’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-115,936
| Closed | -$2.06M | – | 6190 |
|
|
2018
Q3 | $2.06M | Buy |
115,936
+2,166
| +2% | +$38.5K | ﹤0.01% | 3340 |
|
|
2018
Q2 | $1.57M | Buy |
113,770
+80,552
| +242% | +$1.11M | ﹤0.01% | 3603 |
|
|
2018
Q1 | $303K | Buy |
33,218
+31,818
| +2,273% | +$290K | ﹤0.01% | 4590 |
|
|
2017
Q4 | $6K | Sell |
1,400
-2,000
| -59% | -$8.57K | ﹤0.01% | 5628 |
|
|
2017
Q3 | $4K | Buy |
3,400
+1,000
| +42% | +$1.18K | ﹤0.01% | 5692 |
|
|
2017
Q2 | $4K | Sell |
2,400
-13,689
| -85% | -$22.8K | ﹤0.01% | 5605 |
|
|
2017
Q1 | $41K | Buy |
16,089
+1,300
| +9% | +$3.31K | ﹤0.01% | 5211 |
|
|
2016
Q4 | $38K | Sell |
14,789
-200
| -1% | -$514 | ﹤0.01% | 5177 |
|
|
2016
Q3 | $46K | Sell |
14,989
-700
| -4% | -$2.15K | ﹤0.01% | 5083 |
|
|
2016
Q2 | $50K | Sell |
15,689
-51,000
| -76% | -$163K | ﹤0.01% | 4989 |
|
|
2016
Q1 | $207K | Sell |
66,689
-34,198
| -34% | -$106K | ﹤0.01% | 4265 |
|
|
2015
Q4 | $404K | Sell |
100,887
-1,447
| -1% | -$5.79K | ﹤0.01% | 3925 |
|
|
2015
Q3 | $468K | Buy |
102,334
+2,833
| +3% | +$13K | ﹤0.01% | 3872 |
|
|
2015
Q2 | $516K | Sell |
99,501
-1,874
| -2% | -$9.72K | ﹤0.01% | 3980 |
|
|
2015
Q1 | $634K | Buy |
101,375
+33,746
| +50% | +$211K | ﹤0.01% | 3736 |
|
|
2014
Q4 | $426K | Sell |
67,629
-16,011
| -19% | -$101K | ﹤0.01% | 3944 |
|
|
2014
Q3 | $508K | Sell |
83,640
-16,099
| -16% | -$97.8K | ﹤0.01% | 3833 |
|
|
2014
Q2 | $657K | Sell |
99,739
-3,255
| -3% | -$21.4K | ﹤0.01% | 3730 |
|
|
2014
Q1 | $2.45M | Buy |
102,994
+24,322
| +31% | +$579K | ﹤0.01% | 2833 |
|
|
2013
Q4 | $841K | Buy |
78,672
+18,158
| +30% | +$194K | ﹤0.01% | 3503 |
|
|
2013
Q3 | $807K | Sell |
60,514
-3,389
| -5% | -$45.2K | ﹤0.01% | 3464 |
|
|
2013
Q2 | $838K | Buy |
+63,903
| New | +$838K | ﹤0.01% | 3363 |
|